Relmada Therapeutics, Inc. RLMD Issuance Of Restricted Common Stock
Issuance Of Restricted Common Stock at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept rlmd:IssuanceOfRestrictedCommonStock.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s issuance of restricted common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s issuance of restricted common stock?
- Relmada Therapeutics, Inc. (RLMD) reported issuance of restricted common stock of $905.23K in Q1 2025.
- What does issuance of restricted common stock mean?
- The value of common stock issued under restricted stock plans, representing a form of non-cash compensation. This metric tracks the utilization of equity to compensate staff without immediate cash outflows, impacting overall shareholder dilution.